1. Miller RA. Extending life: scientific prospects and political obstacles. Milbank Q. 2002. 80:155–174.
Article
2. Butler RN, Fossel M, Harman SM, Heward CB, Olshansky SJ, Perls TT, Rothman DJ, Rothman SM, Warner HR, West MD, Wright WE. Is there an antiaging medicine? J Gerontol A Biol Sci Med Sci. 2002. 57:B333–B338.
Article
3. Fisher AL, Hill R. Ethical and legal issues in antiaging medicine. Clin Geriatr Med. 2004. 20:361–382.
Article
4. Drazen JM. Inappropriate advertising of dietary supplements. N Engl J Med. 2003. 348:777–778.
Article
5. Draelos ZD. Topical and oral estrogens revisited for antiaging purposes. Fertil Steril. 2005. 291–292.
Article
6. Gruber CJ, Tschugguel W, Schneeberger C, Huber JC. Production and actions of estrogens. N Engl J Med. 2002. 346:340.
Article
7. Shumaker SA, Legault C, Rapp SR, Thal L, Wallace RB, Ockene JK, Hendrix SL, Jones BN 3rd, Assaf AR, Jackson RD, Kotchen JM, Wassertheil-Smoller S, Wactawski-Wende J. WHIMS Investigators. Estrogen plus progestin and the incidence of dementia and mild cognitive impairment in postmenopausal women: the Women's Health Initiative Memory Study: a randomized controlled trial. JAMA. 2003. 289:2651–2662.
Article
8. Nelson HD, Humphrey LL, Nygren P, Teutsch SM, Allan JD. Postmenopausal hormone replacement therapy: scientific review. JAMA. 2002. 288:872–881.
9. Morley JE, Perry HM 3rd. Androgen deficiency in aging men: role of testosterone replacement therapy. J Lab Clin Med. 2000. 1(9):370–378.
Article
10. Lee EJ, Lee D, Lee YS. Clinical experiences of testosterone replacement therapy in frail elderly patients. J Kor Geriatr Soc. 2003. 7:288–294.
11. Calof OM, Singh AB, Lee ML, Kenny AM, Urban RJ, Tenover JL, Bhasin S. Adverse events associated with testosterone replacement in middle-aged and older men: a meta-analysis of randomized, placebo-controlled trials. J Gerontol A Biol Sci Med Sci. 2005. 60:1451–1457.
Article
12. Rudman D, Feller AG, Nagraj HS, Gergans GA, Lalitha PY, Goldberg AF, Schlenker RA, Cohn L, Rudman IW, Mattson DE. Effects of human growth hormone in men over 60 years old. N Engl J Med. 1990. 323:1–6.
Article
13. Blackman MR, Sorkin JD, Munzer T, Bellantoni MF, Busby-Whitehead J, Stevens TE, Jayme J, O'Connor KG, Christmas C, Tobin JD, Stewart KJ, Cottrell E, St Clair C, Pabst KM, Harman SM. Growth hormone and sex steroid administration in healthy aged women and men: a randomized controlled trial. JAMA. 2002. 288:2282–2292.
Article
14. Perls TT, Reisman NR, Olshansky SJ. Provision or distribution of growth hormone for "antiaging": clinical and legal issues. JAMA. 2005. 294:2086–2090.
Article
15. Liu H, Bravata DM, Olkin I, Nayak S, Roberts B, Garber AM, Hoffman AR. Systematic review: the safety and efficacy of growth hormone in the healthy elderly. Ann Intern Med. 2007. 146:104–115.
Article
16. Horani MH, Morley JE. Hormonal fountains of youth. Clin Geriatr Med. 2004. 1(9):275–292.
Article
17. Kamel NS, Gammack J, Cepeda O, Flaherty JH. Antioxidants and hormones as antiaging therapies: high hopes, disappointing results. Cleve Clin J Med. 2006. 1(9):1049–1056. 1058
Article
18. Wilkins CH, Sheline YI, Roe CM, Birge SJ, Morris JC. Vitamin D deficiency is associated with low mood and worse cognitive performance in older adults. Am J Geriatr Psychiatry. 2006. 14:1032–1040.
Article
19. Masoro EJ. Overview of caloric restriction and ageing. Mech Ageing Dev. 2005. 126:913–922.
Article
20. Olshansky SJ, Hayflick L, Carnes BA. Position statement on human aging. J Gerontol A Biol Sci Med Sci. 2002. 57:B292–B297.
Article
21. Grossman T. Latest advances in antiaging medicine. Keio J Med. 2005. 54:85–94.
Article